Dexamethasone downregulates the expression of parathyroid hormone-related protein (PTHrP) in mesenchymal stem cells

Steroids

Volumn 74, Issue 2, 2009, Pages 277-282

  Ahlström, Mikael ^a   Pekkinen, Minna ^a   Lamberg Allardt, Christel ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Glucocorticoids; Mesenchymal stem cells; Osteoblasts; Parathyroid hormone related protein (PTHrP); PTH1R

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MIFEPRISTONE; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BIOSYNTHESIS; BONE MINERALIZATION; CELL CULTURE; CIRCULATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MESENCHYMAL STEM CELL; METHODOLOGY; MINERALIZATION; OSTEOPOROSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BONE AND BONES; CELL DIFFERENTIATION; DEXAMETHASONE; DOWN-REGULATION; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; PARATHYROID HORMONE-RELATED PROTEIN; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RNA, MESSENGER;

EID: 58549100918     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.12.002     Document Type: Article

References (39)

1. Gennari C., and Civitelli R. Glucocorticoid-induced osteoporosis. Clin Rheum Dis 12 (1986) 637-654
2. Reid I.R. Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol 137 (1997) 209-217
3. Canalis E., and Delany A.M. Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci 966 (2002) 73-81
4. Mazziotti G., Angeli A., Bilezikian J.P., Canalis E., and Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metabol 17 (2006) 144-149
5. Canalis E., McCarthy T.L., and Centrella M. Differential effects of continuous and transitient treatment with parathyroid hormone related peptide (PTHrP) on bone collagen synthesis. Endocrinology 126 (1990) 1806-1812
6. Dempster D.W., Cosman F., Parisien M., Shen V., and Lindsay R. Anabolic actions of parathyroid hormone in bone. Endocr Rev 14 (1993) 690-709
7. Horwitz M.J., Tedesco M.B., Gundberg C., Garcia-Ocana A., and Stewart A.F. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrin Metab 288 (2003) 569-575
8. Saag K.G., Shane E., Boonen S., Marin F., Donley D.W., Taylor K.A., et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. New Engl J Med 357 (2007) 2028-2039
9. Asa S.L., Henderson J., Goltzman D., and Drucker D.J. Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab 71 (1990) 1112-1118
10. Suda N., Gillespie M.T., Traianedes K., Zhou H., Ho P.W., Hards D.K., et al. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Phys 166 (1996) 94-104
11. Lanske B., Amling M., Neff L., Guiducci J., Baron R., and Kronenberg H.M. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104 (1999) 399-407
12. Miao D., He B., Jiang Y., Kobayashi T., Sorocéanu M.A., Zhao J., et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115 (2005) 2402-2411
13. Martin T.J. Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115 (2005) 2322-2324
14. Lanske B., Divieti P., Kovacs C.S., Pirro A., Landis W.J., Krane S.M., et al. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139 (1998) 5194-5204
15. Lanske B., and Kronenberg H.M. Parathyroid hormone-related peptide (PTHrP) and parathyroid hormone (PTH)/PTHrP receptor. Crit Rev Eukar Gene 8 (1998) 297-320
16. Iida-Klein A., Guo J., Drake M.T., Kronenberg H.M., Abou-Samra A.B., Bringhurst F.R., et al. Structural requirements of parathyroid hormone/parathyroid hormone-related peptide receptors for phospholipase C activation and regulation of phosphate uptake. Miner Electrol Metab 21 (1995) 177-179
17. Martin T.J. Actions of parathyroid hormone-related peptide and its receptors. New Engl J Med 335 (1996) 736-738
18. Yamamoto I., Shigeno C., Potts Jr. J.T., and Segre G.V. Characterization and agonist-induced down-regulation of parathyroid hormone receptors in clonal rat osteosarcoma cells. Endocrinology 122 (1988) 1208-1217
19. Ahlstrom M., Pekkinen M., Riehle U., and Lamberg-Allardt C. Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells. Bone 42 (2008) 483-490
20. Pekkinen M., Ahlström M., Riehle U., Huttunen M., and Lamberg-Allardt C. Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts. Bone 43 (2008) 84-91
21. Chen H.L., Demiralp B., Schneider A., Koh A.J., Silve C., Wang C.Y., et al. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277 (2002) 19374-19381
22. Choudhary S., Wadhwa S., Raisz L.G., Alander C., and Pilbeam C.C. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signalling pathway. J Bone Miner Res 18 (2003) 1530-1538
23. Jemtland R., Divieti P., Lee K., and Segre G.V. Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP. Bone 32 (2003) 611-620
24. Celic S., Chilco P.J., Zajac J.D., Martin T.J., and Findlay D.M. A type I collagen substrate increases PTH/PTHrP receptor mRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast-like cells. J Endocrinol 150 (1996) 299-308
25. Susperregui A.R., Vinals F., Ho P.W., Gillespie M.T., Martin T.J., and Ventura F. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells. J Cell Physiol 216 (2008) 144-152
26. Bi L.X., Simmons D.J., and Mainous E. Expression of BMP-2 by rat bone marrow stromal cells in culture. Calcif Tissue Int 64 (1999) 63-68
27. Yamamoto I., Potts Jr. J.T., and Segre G.V. Glucocorticoids increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (ROS 17/2). J Bone Miner Res 3 (1988) 707-712
28. Yaghoobian J., and Drueke T.B. Regulation of the transcription of parathyroid-hormone/parathyroid-hormone-related peptide receptor mRNA by dexamethasone in ROS 17/2.8 osteosarcoma cells. Nephrol Dial Transpl 13 (1998) 580-586
29. Haramoto N., Kawane T., and Horiuchi N. Upregulation of PTH receptor mRNA expression by dexamethasone in UMR-106 osteoblast-like cells. Oral Dis 13 (2007) 23-31
30. Oshina H., Shinichi S., Yoshii T., Torigoe I., and Sugata Y. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Bone 41 (2007) 575-583
31. Viereck V., Siggelkow H., Tauber S., Raddatz D., Schutze N., and Hüfner M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 86 (2002) 348-356
32. Subramaniam M., Colvard D., Keeting P.E., Rasmussen K., Riggs L.B., and Spelsberg T.C. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells. J Cell Biochem 50 (1992) 411-424
33. Owen T., Aronow M., Shalhoub V., Barone L., Wilming L.M., Tassinari M.S., et al. Progressive development of the rat phenotype in vitro: reciprocal relationships in expression of genes associated withosteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143 (1990) 420-430
34. Stein G.S., Lian J.B., van Wijnen A.J., and Stein J.L. The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol Biol Reports 24 (1997) 185-196
35. Porter R., Huckle W., and Goldstein A. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 90 (2003) 13-22
36. Ito S., Suzuki N., Kato S., Takahashi T., and Takagi M. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40 (2007) 84-92
37. Haller J., Mikics E., and Makara G.B. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29 (2008) 273-291
38. Mao J., Regelson W., and Kalimi M. Molecular mechanism of RU 486 action: a review. Mol Cell Biochem 109 (1992) 1-8
39. Mercier L., Miller P.A., and Simons Jr. S.S. Antiglucocorticoid steroids have increased agonist activity in those hepatoma cell lines that are more sensitive to glucocorticoids. J Ster Biochem 25 (1986) 11-20